Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Application of Pharmacokinetic/Pharmacodynamic Modeling to Bridge Mouse Antitumor Efficacy and Monkey Toxicology Data for Determining the Therapeutic Index of an Interleukin-10 Fc Fusion Protein.
Journal: Frontiers in pharmacology
Published: December 04, 2021
Correction to: A window-of-opportunity trial of the CXCR1/2 inhibitor reparixin in operable HER-2-negative breast cancer.
Journal: Breast cancer research : BCR
Published: May 22, 2020
The effect of sonidegib (LDE225) on the pharmacokinetics of bupropion and warfarin in patients with advanced solid tumours.
Journal: British journal of clinical pharmacology
Published: March 16, 2020
Assessing an ASCO Decision Aid for Improving the Accuracy and Attribution of Serious Adverse Event Reporting From Investigators to Sponsors.
Journal: Journal of oncology practice
Published: October 25, 2019
A window-of-opportunity trial of the CXCR1/2 inhibitor reparixin in operable HER-2-negative breast cancer.
Journal: Breast cancer research : BCR
Published: March 22, 2019
A Phase Ib/II Trial of the First-in-Class Anti-CXCR4 Antibody Ulocuplumab in Combination with Lenalidomide or Bortezomib Plus Dexamethasone in Relapsed Multiple Myeloma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 25, 2019
Evaluation of pharmacokinetics and safety of cetuximab with cisplatin/carboplatin in patients with advanced solid tumor: Result from phase II studies.
Journal: Pharmacology research & perspectives
Published: September 19, 2018
Streamlining Adverse Events Reporting in Oncology: An American Society of Clinical Oncology Research Statement.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 14, 2017
Drug screening to target nuclear orphan receptor NR4A2 for cancer therapeutics.
Journal: Translational lung cancer research
Published: November 09, 2017
Sponsors' and investigative staffs' perceptions of the current investigational new drug safety reporting process in oncology trials.
Journal: Clinical trials (London, England)
Published: March 28, 2017
Safety and Activity of Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha-Targeting Antibody-Drug Conjugate, in Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer: A Phase I Expansion Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 29, 2016
Last Updated: 09/26/2026